J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2B
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on …
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on …
It’s not being talked about enough. This market move off the November lows and the Fed pivot — signaling an end to the central bank’s rate-hiking cycle — is one …
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker …
CNBC’s Jim Cramer outlined the ways that Federal Trade Commission chair Lina Khan has attempted to stop mergers and acquisitions from going through, hurting stock portfolios in the process. “Khan’s …
My top 10 things to watch Thursday, Dec. 14 1. U.S. stocks are higher in premarket trading Thursday, with S & P 500 futures up 0.46%. Equities rallied Wednesday after …
In the high-stakes cloud-computing battle, Microsoft is outpacing its top rivals. Third-quarter results are in for most mega-cap tech companies after a big week for tech earnings. On the cloud …
Here are the most important news items that investors need to start their trading day: 1. Bond yield boost U.S. stock futures slid Monday morning as the 10-year Treasury note …
Many of the top financial donors to U.S. Sen. Bob Menendez will not say whether they will continue supporting his campaign in the face of a scathing federal bribery indictment …
A worker handles a bottle of Merck & Co. and Ridgeback Biotherapeutics LPs Molnupiravir antiviral medication in a warehouse in Shoham, Israel, on Jan. 18, 2022. A fourth dose of the …
Ohio Governor Mike DeWine, right, shakes hands with Judge Thomas Rose of the U.S. District Court Southern District of Ohio after taking his oath of office, Monday, Jan. 14, 2019, …